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Pseudomonas aeruginosa is a Gram negative pathogenic bacterium involved in
many human infections including otitis, keratitis, pneumonia, and diabetic foot ulcers.
P. aeruginosa uses a communication system, referred to as quorum sensing (QS), to
adopt a group behavior by synchronizing the expression of certain genes. Among the
regulated traits, secretion of proteases or siderophores, motility and biofilm formation
are mainly involved in the pathogenicity. Many efforts have been dedicated to the
development of quorum sensing inhibitors (QSI) and quorum quenching (QQ) agents to
disrupt QS. QQ enzymes have been particularly considered as they may act in a catalytic
way without entering the cell. Here we focus on the lactonase SsoPox which was
previously investigated for its ability to degrade the signaling molecules, acyl-homoserine
lactones, in particular on the engineered variant SsoPox-W263I. We highlight the
potential of SsoPox-W263I to inhibit the virulence of 51 clinical P. aeruginosa isolates
from diabetic foot ulcers by decreasing the secretion of two virulence factors, proteases
and pyocyanin, as well as biofilm formation. We further compared the effect of
SsoPox-W263I to the comprehensively described QSI, 5-fluorouracil and C-30. We
found the lactonase SsoPox-W263I to be significantly more effective than the tested QSI
at their respective concentration optimum and to retain its activity after immobilization
steps, paving the way for future therapeutic applications.
Keywords: quorum quenching, quorum sensing, lactonase, pyocyanin, bacterial virulence, biofilm, proteases,
anti-bacterial agents
INTRODUCTION
Pseudomonas aeruginosa is a human opportunistic pathogen involved in many infection types and
which causes serious health complications (Stover et al., 2000; Driscoll et al., 2012). In 2006/2007,
this Gram negative bacterium alone was responsible for 8% of general healthcare associated
infections in the USA (Sievert et al., 2013). P. aeruginosa is involved in both community-acquired
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and hospital-acquired infections including otitis, keratitis, wound
and burn infections, pneumonia and urinary tract infections
(Driscoll et al., 2012). Furthermore, P. aeruginosa is, along with
Staphylococcus aureus, the most common pathogen isolated from
diabetic foot infections notably in South East Asia, and is also
highly involved in infections when an alteration of the skin occurs
(Driscoll et al., 2012).
Many bacteria, including P. aeruginosa, use a molecular
communication system, referred to as quorum sensing (QS),
to synchronize the expression of certain genes and adopt a
group behavior. Among QS-regulated traits, virulence factors
production such as pyocyanin and proteases (Hentzer, 2003),
motility (Daniels et al., 2004) and biofilm formation (Whiteley
et al., 2001) are involved in the development of infections.
Quorum sensing in P. aeruginosa depends on four different
hierarchically organized systems: Las, Iqs, Rhl and Pqs. The
first system to be activated is the Las system which depends on
the production and perception of an acyl-homoserine lactone
(AHL): N-(3-oxododecanoyl)-homoserine lactone (OdDHL or 3-
oxo-C12 AHL; Gambello and Iglewski, 1991; Pearson et al., 1994).
Induction of the Las system triggers the expression of the Las
protease and elastase and activates the other QS systems. Despite
its dominant role in the QS circuitry, eliminating LasR activation
only results in a delayed activation of the Pseudomonas quinolone
signal (PQS) system but does not completely eliminate QS
(Diggle et al., 2003). In addition, the QS system of P. aeruginosa
is interconnected with other regulatory networks involved in
environmental cues such as phosphate, iron and oxygen sensing
(Lee and Zhang, 2014).
Regarding the importance of bacterial communication in the
development of virulence, strategies for QS disruption, known
as quorum quenching (QQ), have emerged to maintain bacteria
in a commensal lifestyle. To this end, quorum sensing inhibitors
(QSI) and QQ enzymes have been particularly considered (Dong
et al., 2007; Kalia, 2013; Tang and Zhang, 2014; Brackman
and Coenye, 2015; Fetzner, 2015). QSI, such as brominated
furanones, aim to prevent bacteria from perceiving endogenous
QS molecules. Pyrimidine analog has also been reported as a
QS disruptor (Ueda et al., 2009). QQ enzymes such as acylases
or lactonases degrade AHL signals (Bzdrenga et al., 2016; Rémy
et al., 2016a). Among these, the enzyme SsoPox, isolated from
the archaea Sulfolobus solfataricus, has been considered based
on both its lactonase activity and tremendous stability due to its
extremophile origin (Rémy et al., 2016b).
Many QQ examples have been reported and describe the
reduction of virulence factor secretion (e.g., siderophores,
proteases, rhamnolipids, etc.; Diggle et al., 2007; Welsh and
Blackwell, 2016) and/or biofilm formation, especially using QSI
molecules (Hentzer, 2003). However, a large proportion of these
reports are dedicated to investigating model strains P. aeruginosa
PAO1 and PA14, and only a few reports have described the
response of clinical isolates to QS disruption, whereas natural
isolates frequently harbor mutations in QS genes (Ciofu et al.,
2010).
In this article, we investigated the effectiveness of the QQ
enzyme SsoPox-W263I, a variant of SsoPox with increased
catalytic effectiveness against 3-oxo-C12 AHL (Hiblot et al.,
2013; Rémy et al., 2016b), previously reported as being efficient
to drastically reduce the mortality in a rat pneumonia model
(Hraiech et al., 2014), to modulate virulence factors in 51
clinical P. aeruginosa isolates collected from diabetic foot ulcers.
We also compared its QQ potential to the most common
QSI, the brominated furanone C-30 and the pyrimidine analog
5-fluorouracil (5-FU), by quantifying three virulence factors:
pyocyanin production, protease secretion and biofilm formation
(Ren et al., 2001; Ueda et al., 2009). Finally the lactonase was
immobilized to assess its ability to functionalise medical devices
and was proved to maintain sufficient activity for QQ.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Experiments were performed with P. aeruginosa strains from
samples held by the Department of Microbiology of the Nîmes
University Hospital. The strains were isolated from diabetic
patients with a suspected newly presenting episode of diabetic
foot infection for a period of 1 year (2014). All the patients
received an oral information, were anonymized and gave a
non-opposition statement to bacterial storage. This study was
approved by the local ethics committee (South Mediterranean
III) and was carried out in accordance with the Declaration of
Helsinki as revised in 2008. The samples were frozen at −80◦C.
Bacterial strains were cultivated on Luria Bertani (LB) agar plates
at 37◦C.
The model strains P. aeruginosa PAO1 and PA14 (Taxonomy
ID: 208964 and 652611) and the clinical isolates were inoculated
from a single colony and pre-cultivated in LB (10 g l−1 NaCl,
10 g l−1 tryptone, 5 g l−1 yeast extract) for 6 h at 37◦C with
shaking at 650 rpm. Subsequently, 3 ml of LB supplemented
with 2% sheep blood (Biomérieux, France) was inoculated with
3 µl pre-culture and incubated at 37◦C with shaking at 650
rpm. Pyocyanin production and protease activity were measured
24 h post-inoculation. Biofilm weight was determined 48 h
post-inoculation.
The enzyme SsoPox was added at 0.5 mg ml−1 and the QSI 5-
FU and C-30 (Sigma) were used at 60 and 30 µM, respectively,
as determined by a dose response experiment (Supplementary
Figures 1–3).
Bacterial Identification
All strains were checked using Matrix-assisted laser desorption
ionization–time of flight (MALDI-TOF) as previously described
(Seng et al., 2009). In brief, isolates were grown overnight on
blood agar at 37◦C under aerobic conditions. Single colonies were
applied as a thin film to a 96-spot steel plate (BrukerDaltonics)
and allowed to visibly dry at room temperature. Subsequently,
2 µl of MALDI matrix (saturated solution of alpha-cyano-4-
hydroxy-cinnamic acid, 500 µl HPLC-grade acetonitrile, 475 µl
HPLC-grade water, 25 µl trifluoroacetic acid) was applied on
the spots and dried at room temperature. Isolates were tested in
duplicate by MALDI-TOF mass spectrometry. The MALDI target
plate was introduced into a microflex LT MALDI-TOF mass
spectrometer for automated measurement and controlled by the
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FlexControl 3.3 (Bruker R©) program. The spectra were collected in
a mass range between 2,000–20,000 m/z then analyzed using the
Bruker Biotyper 3.0 software package and compared to reference
spectra for identification.
Protein Production and Purification
Enzyme production was performed using E. coli BL21 (DE3)-
pGro7/GroEL strain (TaKaRa) carrying plasmid pET22b-SsoPox-
W263I as previously described (Hiblot et al., 2012, 2013). In
brief, cells were grown in ZYP medium supplemented with
100 µg ml−1 ampicillin and 34 µg ml−1 chloramphenicol at
37◦C until OD600nm reached 0.8–1. L-arabinose was added to a
final concentration of 0.2% (w/v) in order to induce chaperones
expression. Subsequently, 0.2 mM CoCl2 was added and the
temperature was reduced to 23◦C for an additional 20 h. Cells
were harvested by centrifugation (4,400 g, 4◦C, 20 min), the
supernatant was discarded and the pellet was resuspended in
lysis buffer [50 mM HEPES pH 8.0, 150 mM NaCl, 0.2 mM
CoCl2, 0.25 mg ml−1 lysozyme, 0.1 mM Phenylmethylsulfonyl
fluoride (PMSF) and 10 µg ml−1 DNaseI] and stored at −80◦C
overnight. Frozen cells were thawed at 37◦C for 15 min and
disrupted by three 30 s sonication steps (QSonica sonicator Q700;
amplitude at 45). Cell debris was removed by centrifugation
(21,000 g, 4◦C, 15 min). Crude extract was incubated for
30 min at 80◦C and was further centrifuged to precipitate
E. coli proteins (21,000 g, 4◦C, 30 min). SsoPox-W263I was
concentrated by overnight ammonium sulfate precipitation (75%
saturation), and resuspended in activity buffer (50 mM HEPES
pH 8.0, 150 mM NaCl, 0.2 mM CoCl2). Remaining ammonium
sulfate was eliminated via desalting (HiPrep 26/10 desalting,
GE Healthcare; ÄKTA Avant). The obtained protein sample
was concentrated to 2 ml and subsequently loaded onto a size-
exclusion chromatography column and purified to homogeneity
(HiLoad 16/600 SuperdexTM 75pg, GE Healthcare; ÄKTA Avant).
The purity of the protein was checked by 10% SDS-PAGE
(Supplementary Figure 4) separation and protein concentration
was measured using a NanoDrop 2000 spectrophotometer
(Thermo Scientific).
Proteolytic Activity
Cell-free culture supernatants were prepared by centrifugation
for 5 min at 12,000 g. Protease activity was determined using
azocasein (Sigma, St. Louis, MO, USA) as a substrate (Chessa
et al., 2000). The reaction was performed in Phosphate-buffered
saline (PBS) solution pH 7.0 with 50 µl of azocasein (30 mg ml−1
in water) and with 25 µl of culture supernatant for a final volume
of 750 µl. The reaction was incubated at 37◦C for 1 h and
stopped by adding 125 µl of 20% (w/v) trichloroacetic acid. The
blank assay was realized using 25 µl of culture medium with and
without 0.5 mg ml−1 of SsoPox. After centrifugation at 12,000 g
for 5 min, the absorbance of the supernatant was measured at
OD366nm using a plate reader (Synergy HT, BioTek, USA).
Pyocyanin Production
Pyocyanin was extracted from 500 µl of cell-free supernatant
using 250 µl of chloroform. The mix was vortexed for 20 s, and
centrifuged at 12,000 g for 5 min. The absorbance of the lower
organic phase was measured at OD690nm using a plate reader
(Synergy HT, BioTek, USA; Price-Whelan et al., 2007).
Biofilm Weight Measurement
After 48 h, each culture was sieved through a 100 µm pore-size
cell strainer (Corning, New York, NY, USA) to separate biofilm
from planktonic cells. The biofilm was washed with 2 ml PBS and
centrifuged at 600 g for 5 min. Biofilms were weighed directly
in the cell strainers using a precision scale (Supplementary
Figure 5).
Immobilization
In a 25 cm2 culture flask (Corning, New York, NY, USA),
1 ml of 5% Impranil R© DLU polyurethane (Covestro, Leverkusen,
Germany) mixed with 20 mg ml−1 of SsoPox-W263I and 0.5%
Glutaraldehyde (Sigma) in purified water was dried over 12 h at
37◦C. As a control, the same volume of activity buffer was added
instead of SsoPox-W263I. Before being used for culture, the flask
was rinsed with 3 ml of purified water and then 3 ml of LB.
Enzymatic Activity Measurement
Enzymatic activities were measured after 24 h based on the
paraoxonase activity of SsoPox using ethyl paraoxon as a
substrate and the apparition of para-nitrophenol, paraoxon
degradation product, was followed at OD405nm.
Released enzyme was measured after 24 h from culture
supernatants. 5 µl of cell-free culture supernatant was transferred
into a 96-well plate containing 95 µl of activity buffer (50 mM
HEPES, 150 mM NaCl, pH 8). Then 100 µl of 2 mM ethyl
paraoxon (Sigma) in activity buffer was added and OD405nm
was monitored during 10 min with a plate reader (Synergy
HT, BioTek, USA) and the slope corresponding to paraoxon
degradation kinetics was calculated.
Fixed enzyme was determined by adding 3 ml of a 1 mM ethyl
paraoxon solution. After 3 min of incubation with shaking (300
rpm), 200 µl of paraoxon solution was transferred into a 96-well
plate and OD405nm was measured. The slope (OD min−1) was
calculated and compared to a standard with a known enzyme
concentration to calculate the amount of enzyme immobilized in
the PU coating.
RESULTS
Dose-Response Determination
Pseudomonas aeruginosa model strains PAO1 and PA14 were
used to determine the optimal concentrations of the QQ
enzyme SsoPox and the QSI 5-FU and C-30 to decrease
virulence factor production. Time points for sampling were
determined by performing dose response experiments at
different concentrations (Supplementary Figures 1–3). Under
our conditions and in the absence of quenchers, protease
and pyocyanin levels were similar for both strains (data not
shown). The use of SsoPox did not induce any delay in growth
and maximal quenching was obtained for a concentration of
0.5 mg ml−1 of enzyme corresponding to 14.5 µM after 16 h
of cultivation (Supplementary Figure 1). At this time point,
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FIGURE 1 | Measurable virulence factor expression among the 51 clinical isolates of P. aeruginosa. (A) Venn diagram describing the distribution of the 51
strains according to their production of virulence factors. (B) Proteolytic activities are presented according to OD366nm value ranging from 0 to 1.37. Pyocyanin values
represent the OD690nm and range from 0 to 1. Biofilm values correspond to the weight of biofilm formed after 48 h for 3 ml of culture and range from 0 to 289 mg.
pyocyanin production was almost completely abolished for
both strains and protease production was reduced to 10% as
compared to the control (untreated sample) for PAO1 and 43%
for PA14. Biofilm formation was measured after 48 h to allow
complete biofilm formation and direct weighing of cell aggregates
(Supplementary Figure 5). The addition of SsoPox (0.5 mg ml−1)
reduced biofilm formation by 90% for PAO1 and 60% for PA14,
and increasing SsoPox concentration did not enhance quenching.
The QSI molecule 5-FU only weakly impacted production of
pyocyanin and protease in PAO1 but had a greater influence on
PA14, with pyocyanin and protease productions reduced to 10
and 50%, respectively, compared to the untreated culture. Biofilm
formation was reduced in both strains when concentrations of 5-
FU of 60 µM or higher were used. According to these results,
QQ of the clinical isolates was tested using 0.5 mg ml−1 SsoPox
or 60 µM 5-FU and 30 µM C-30. The same values were also
reported in previous studies (García-Contreras et al., 2013, 2015).
Pyocyanin and protease productions were determined after 24 h
and biofilm formation 48 h post-inoculation.
Importantly, the addition of 5-FU to the culture led to a delay
in growth, but this delay was recovered after 24 h for PAO1
(Supplementary Figure 6). The second QSI molecule, C-30, had
much less impact in our experiment set-up as protease level
remained up to 90% of the control for both PAO1 and PA14, and
pyocyanin production was not reduced.
Quenching of Virulence Factors by
SsoPox
In the experimental conditions used here, the two model strains
PAO1 and PA14 both produced the three virulence factors
tested. Among the 51 clinical isolates of P. aeruginosa, 16 strains
produced the three virulence factors studied, 13 produced two
virulence factors and 22 produced only one virulence factor
(Figure 1). Proteolytic activities ranged from 0.47 to 1.37 with a
median value at 1.08 (Figure 2A). Median pyocyanin production,
among the 26 strains producing pyocyanin, was measured at 0.17
and this virulence factor showed the highest variations ranging
from 0.01 to 1.00 (Figure 2B). Finally, the most common feature
between the clinical isolates was biofilm formation as 42 strains
out of 51 produced biofilm. Among these strains, the median
value for wet biofilm was 73 mg with values ranging from 15 to
289 mg (Figure 2C). SsoPox was used at a concentration of 0.5 mg
ml−1 and pyocyanin and protease quantities were determined
after 24 h. In these conditions, SsoPox reduced protease activity
of 26 out of 28 strains, with 20 of them being reduced by more
than 50% and complete quenching was achieved for 16 of them.
No clinical isolate harbored a higher value upon treatment with
SsoPox than without (Figure 3A). Pyocyanin production was
reduced in 25 strains out of 26 and 20 of them were reduced
by more than half the control level. Furthermore, pyocyanin
production was completely eliminated in six strains. As noticed
for protease production, no strain had increased pyocyanin
production when the QQ enzyme SsoPox was added (Figure 3B).
Biofilm was reduced in 37 strains out of 42, 36 of them were
reduced by more than half and 20 of them completely lost
their ability to grow in biofilms. Unlike pyocyanin and protease
production, one clinical isolate, A12, had a slightly thicker biofilm
upon treatment with SsoPox than without but this difference was
not statistically significant (Figure 3C).
Comparison between SsoPox and the
QSI 5-FU and C-30
To compare QQ potentials between SsoPox and QSI molecules,
the 16 clinical strains producing the three virulence factors were
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FIGURE 2 | Distribution plots of virulence factor values with and
without quenching treatment of the 51 clinical isolates. Values of
proteolytic activity (A), pyocyanin quantity (B) and biofilm formation (C) are
shown as whiskers plots down to the 5th percentile and up to the 95th.
Control samples (without enzyme) are shown in red while SsoPox treated
samples are in green. SsoPox was added to cell cultures at a concentration of
0.5 mg ml−1. Points below and above the whiskers represent outlier values.
tested with 0.5 mg ml−1 SsoPox, 30 µM C-30, 60 µM 5-FU and
both QSI. Under our conditions, C-30 showed very little QQ
potential either with the model strains PAO1 and PA14 or with
the clinical isolates (Figure 4 and Supplementary Figure 3). Only
five strains showed a slight decrease in protease production, the
maximum decrease measured was 20% for strain B2. Pyocyanin
production was only reduced for two strains, B10 and B11,
with ratios of 0.57 and 0.39, respectively. Concerning biofilm
formation only one strain showed a statistically significant
decrease with a ratio of 0.4 as compared to the control. More
importantly, many strains showed significantly higher virulence
factor production after treatment with C-30.
The results obtained using 5-FU indicated more QQ activity
than C-30 in these experimental conditions. Indeed, seven strains
out of 16 presented decreased proteolytic activity, two strains
had decreased pyocyanin production and 10 strains formed less
biofilm upon treatment with 5-FU. The combination of both QSI
molecules did not lead to an increase in quenching potential as
compared to the use of 5-FU alone. SsoPox was the most active
QQ agent, reducing proteolytic activities in every strain tested,
reducing pyocyanin production in all but one strain and reducing
biofilm formation in 12 strains out of 16.
Immobilization
To prove the effectiveness of SsoPox-W263I in medical
device-like conditions, the enzyme was immobilized in a
waterborne polyurethane coating with the cross-linking agent
glutaraldehyde. The influence of the PU coating without enzyme
on growth and virulence factor production of PAO1 model
strain was assessed to ensure that PU did not have a major
impact on bacterial metabolism. Neither growth nor protease
production differed. Pyocyanin and biofilm productions were
slightly impacted with a decrease of pyocyanin production
and an increase in biofilm formation. Despite these differences
inherent to PU coating the impact of enzyme could be
measured and quenching was successfully achieved (Figure 5).
Indeed, in the same culture conditions as free enzymes, the
immobilized SsoPox was able to decrease pyocyanin production
by 2.1, protease activity by 24 and biofilm quantity by
6.5 as compared to the control with polyurethane coating.
Enzyme release was determined by measuring enzymatic activity
of culture supernatants after 24 h of growth. No enzyme
activity was detected in culture supernatants indicating that
the immobilization is effective and no enzyme is released after
fixation. About 200 µg of active enzyme were detected in 25 cm2
flask corresponding to a final concentration of 8–10 µg cm−2.
In these conditions, the SsoPox coating was effective in reducing
significantly the production of all tested virulence factors.
DISCUSSION
Foot ulcers are common in diabetic patients mainly due
to arteriopathy and neuropathy. The risk of lower-extremity
amputation for patients suffering from diabetes is up to 155 times
higher than for non-diabetic people (Lavery et al., 2006; Richard
et al., 2011). Diabetic foot ulcers are often polymicrobial, bacteria
from various types can maintain a chronic infection on their own,
or act synergistically in a pathogenic biofilm to cause infection.
P. aeruginosa is one of the most frequent pathogens isolated in
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FIGURE 3 | Quenching of virulence factors using SsoPox. For each strain, bars represent the mean ratios of protease (A), pyocyanin (B) and biofilm (C) levels
between the treated culture with 0.5 mg ml−1 SsoPox versus the untreated culture of three experiments. Error bars represent the standard deviations of three
replicated experiments. ∗p-values<0.05 according to Student’s t-test.
diabetic foot ulcers, particularly in warmer countries (Asia and
Africa) where Gram-negative bacilli are more prevalent (Rastogi
et al., 2016). This bacterium has developed many strategies to
counteract antimicrobial treatments such as antibiotics (Hancock
and Speert, 2000). Biofilm formation (Whiteley et al., 2001),
β-lactamases (Lauretti et al., 1999) and increased eﬄux rates
(Poole et al., 1993) are part of the molecular arsenal that
P. aeruginosa deploys to resist anti-bacterial agents, resulting
in severe economic and health outcomes (Carmeli et al., 1999).
The quest for new therapeutic strategies to fight P. aeruginosa
infections is highly challenging.
Remarkably, among the 51 strains assayed in this study,
the clinical isolates of P. aeruginosa harbored distinct
phenotypes with only 16 strains producing the three
virulence factors as the model strains PAO1 and PA14.
Most strains produced only one or two of the studied
virulence factors in the conditions tested. In addition, the
levels of each virulence factor were highly variable from one
isolate to another. Such phenotypic variations have already
been reported and underline the necessity to test potential
therapeutic molecules on clinical isolates (Grosso-Becerra et al.,
2014).
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FIGURE 4 | Comparison of quenching by SsoPox and QSI C-30 and 5-FU. For each strain, bars represent the mean ratios of protease (A), pyocyanin (B) and
biofilm (C) levels between the treated culture with optimal concentrations of quorum quenching (QQ) agents (0.5 mg ml−1 SsoPox, or 30 µM C-30 and/or 60 µM
5-FU) versus the untreated culture of three experiments. Error bars represent the standard deviations of three replicated experiments. ∗p-values<0.05 according to
Student’s t-test.
In this study, the ability of the lactonase variant SsoPox-
W263I to decrease virulence in clinical isolates of P. aeruginosa
was evaluated. This variant was selected for an increased
catalytic efficiency toward 3-oxo-C12 AHL (45-fold increase as
compared to the wild-type enzyme) while maintaining a high
thermostability (Tm = 88◦C). Three virulence factors were
assayed: pyocyanin production, protease secretion and biofilm
formation. SsoPox-W263I was shown to drastically affect the
synthesis of both virulence factors and biofilm while the QSI C-30
and 5-FU only showed moderate abilities, at their optimum dose,
in the same conditions. These results were obtained in vitro using
a rich medium in which bacterial growth is fast and without pre-
treatment of the cultures with the QSI which could explain their
poor activity. Notably, the use of 5-FU on PAO1 cultures led to a
reduced growth rate of bacteria, possibly indicating some level of
toxicity.
Even though SsoPox targets, in principle, only one QS system
used by P. aeruginosa its QQ potential was very effective.
Proteolytic activity was decreased by at least half in 67% of the
strains, pyocyanin production in 68% and biofilm in 82%. The use
of lactonases as biocontrol agents in bacterial infection therefore
seems very promising. Moreover, upon lactonase treatment,
no increase in proteolytic activity or pyocyanin production
was noticed, only biofilm formation of one strain was slightly
enhanced upon treatment with SsoPox but was not statistically
relevant. Conversely, the increase of virulence factor production
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FIGURE 5 | Quenching P. aeruginosa PAO1 with enzyme immobilized in polyurethane (PU). Bars represent the mean ratios of pyocyanin (A), protease (B)
and biofilm (C) levels between the treated culture with immobilized SsoPox (PU with SsoPox) versus the untreated culture containing a PU coating or without coating
(No PU). Error bars represent the standard deviations of two replicate experiments. ∗p-values<0.05 according to Student’s t-test using control with PU as reference.
after treatment with QSI molecules has already been reported,
when clinical strains of P. aeruginosa isolated from cystic fibrosis
patients were treated with C-30 and 5-FU and when isolates
from diverse origins (urinary tract, wound infection, blood and
respiratory tract) were exposed to natural inhibitors such as
catechin, caffeine, curcumin and salicylic acid (García-Contreras
et al., 2013, 2015; Sethupathy et al., 2016). Similar observations
are made in this study with several tested isolates after treatment
with C-30 or 5-FU but never after treatment with SsoPox,
showing that SsoPox does not induce any deleterious effect
in vitro as compared to the QSI under the conditions used here.
Resistance of P. aeruginosa clinical isolates to QSI has
previously been described (Maeda et al., 2012; García-Contreras
et al., 2013, 2015). The reported resistance mechanisms involved
increased activity of antibiotic eﬄux pumps to move C-30
more efficiently out of the bacterial cell. Such mutations were
obtained in vitro by evolving a model strain in the presence
of C-30. They were also identified in natural isolates that had
never been challenged with C-30. Other reported mutations
induce a reduced uptake of C-30 (García-Contreras, 2016).
Nevertheless such mutant strains would not show any resistance
to SsoPox quenching potential as the enzyme neither enters
the bacteria nor binds to a cellular receptor. Even though no
growth delay was observed using SsoPox, suggesting no or
very low selection pressure, other resistance mechanisms could
appear. Bacteria could increase AHL production, produce an
enzyme inhibitor, or modify the AHL molecule to prevent
its recognition by the enzyme. However, AHL overproduction
would represent a significant metabolic cost that would
decrease the bacterial fitness in non-selective environments.
Modifying the AHL molecules would involve several mutations,
first at the level of the synthase then at the level of the
receptor. Furthermore, such resistance mechanisms could be
easily circumvented by increasing the amount of enzyme
or by broadening its spectrum to target more diverse AHL
molecules.
Lastly, SsoPox was successfully immobilized in the cultivation
flasks using polyurethane and glutaraldehyde. Under these
conditions the enzyme was still active and QQ was achieved
with a reduction of each virulence factor tested. In addition, no
release of the enzyme was measured. Other enzymes have already
been described and successfully used to quench P. aeruginosa.
For example acylases from Pectobacterium atrosepticum and
Agrobacterium tumefaciens have been used to degrade AHL
from P. aeruginosa (Sunder et al., 2016). Even though the
acylases efficiently decreased PAO1 virulence factor production,
the stability of these enzymes at high temperatures (above
60◦C) was really poor offering a limited industrial potential.
The acylase from Aspergillus meleus was immobilized in coatings
and decreased P. aeruginosa biofilm formation (Ivanova et al.,
2015; Grover et al., 2016). Nevertheless these reports do not
mention the industrial potential of such enzymes regarding their
stability and tolerance to solvents, temperature, and bacterial
secretions. Regarding the use of lactonases as QQ agents, MomL,
a lactonase produced by the marine bacterium Muricauda olearia
was showed to degrade AHL in vitro and to decrease virulence
of P. aeruginosa PAO1 (Tang et al., 2015). To our knowledge,
unlike QSI no QQ enzyme was tested on a wide range of
clinical isolates but only on model strains which behaviors differ
from natural isolates. The biochemical characteristics of SsoPox-
W263I have already been assessed and reported (Hiblot et al.,
2013; Rémy et al., 2016b). The data presented here, together
with the high resistance of SsoPox and its potential to meet
industrial constraints, open the way to incorporating SsoPox
in medical devices such as functionalised catheters and anti-
virulence dressings. To fully assess the quenching potential of
SsoPox and its effect on virulence, infection models should be
used.
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